论文信息 - Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group. - 字舞流文

Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.

C. Balañà | A. Abad | A. Font | C. Camps | J. Vicent | J. Sánchez | B. Masuti

[1] J. Carles,et al. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[2] S. Schoenike,et al. Ifosfamide and mesna. , 1990, Clinical pharmacy.

[3] J. Ajani,et al. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4] G. T. Budd,et al. Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5] O. Dalesio,et al. Phase II study of epirubicin in advanced adenocarcinoma of the pancreas. , 1985, European journal of cancer & clinical oncology.